Akihiko Miyanaga

MiR-134/487b/655 Cluster Regulates TGF-β–Induced Epithelial–Mesenchymal Transition and Drug Resistance to Gefitinib by Targeting <i>MAGI2</i> in Lung Adenocarcinoma Cells

Kazuhiro Kitamura, Masahiro Seike, Tetsuya Okano et al. · Molecular Cancer Therapeutics · 2013 · 186 citations · Full text

Medicine, Cancer Biology, Oncology +17

Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing

Akihiko Miyanaga, Mari Masuda, Koji Tsuta et al. · Journal of Thoracic Oncology · 2015 · 112 citations · Full text

Medicine, Genetics, Oncology +14

Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model

Akihiko Miyanaga, Akihiko Gemma, Rintaro Noro et al. · Molecular Cancer Therapeutics · 2008 · 96 citations

Medicine, Oncology, Pharmacology +12

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

Nobuhiko Nishijima, Masahiro Seike, Chie Soeno et al. · International Journal of Oncology · 2016 · 83 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of ABCB1 Overcomes Cancer Stem Cell–like Properties and Acquired Resistance to MET Inhibitors in Non–Small Cell Lung Cancer

Teppei Sugano, Masahiro Seike, Rintaro Noro et al. · Molecular Cancer Therapeutics · 2015 · 76 citations

Medicine, Oncology, Pharmacology +16